296. Inside Oligometastatic Breast Cancer: Kacie Flaherty and Joyce Dini on Treatment, Grief, and Joy

Love the podcast? Send us a text!In this episode of Breast Cancer Conversations, Laura Carfang speaks with Kacie Flaherty and Joyce Dini about life with oligometastatic breast cancer. They share how their diagnoses unfolded, what treatment decisions looked like, and how they’ve learned to navigate uncertainty while staying grounded in what matters most.Together, they discuss:The differences between metastatic and oligometastatic breast cancer.What curative-intent treatment can look like in practice.How diagnosis and treatment affect relationships, fertility, and identity.The mental health challenges of living with cancer day to day.The importance of boundaries, advocacy, and choosing joy.Kacie and Joyce also reflect on the support they’ve found in community, the language that helped them better understand their disease, and the ways they continue to reclaim agency in the face of something they cannot fully control.This episode is especially meaningful for patients, caregivers, and anyone seeking an honest conversation about breast cancer, treatment complexity, and emotional survival.Topics covered: oligometastatic breast cancer, metastatic breast cancer, curative intent, treatment decisions, cancer and relationships, fertility loss, mental health, grief, resilience, patient advocacy, community support, choosing joy.Support the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work.